[Influence of a combinated adelphan-esidrix and clonidin therapy on blood pressure and renal function in renal hypertension].
D000328:Adult; D000814:Aniline Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D001795:Blood Pressure Determination; D001806:Blood Urea Nitrogen; D004357:Drug Synergism; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use*; D006834:Hydrazines / Q000008:administration & dosage; D006852:Hydrochlorothiazide / Q000008:administration & dosage / Q000627:therapeutic use*; D006977:Hypertension, Renal / Q000188:drug therapy*; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D012110:Reserpine / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D000814:Aniline Compounds; D006834:Hydrazines; D007093:Imidazoles; D006852:Hydrochlorothiazide; D006830:Hydralazine; D012110:Reserpine
Der Einfluss einer Kombinationstherapie mit Adelphan-Esidrix und Clonidin auf Blutdruck und Nierenfunktion bei renaler Hypertonie.